文献速递慢性静脉疾病

机械化学消融与热消融治疗大隐静脉功能不全的三年随机对照试验结果

Three-year results of a randomized controlled trial comparing mechanochemical and thermal ablation in the treatment of insufficient great saphenous veins.
PubMed 文献 · J Vasc Surg Venous Lymphat Disord · 2020-08-12

这项随机对照试验比较了机械化学消融(MOCA)与静脉腔内激光消融(EVLA)和射频消融(RFA)治疗单侧大隐静脉(GSV)功能不全的三年结果。132例符合标准并愿意参与的患者被随机分配(MOCA:EVLA:RFA=2:1:1),最终117例接受治疗。三年时MOCA的闭塞率显著低于EVLA或RFA(82% vs 100%;P = .005),生活质量组间相似;MOCA组术前GSV直径大于7 mm者更易再通,一年时观察到的近端GSV部分再通在随访中进展。

要点

  • 三年闭塞率MOCA显著低于热消融(82% vs 100%;P = .005)。
  • MOCA组术前GSV直径大于7 mm者随访期更易再通。
  • 一年时近端GSV部分再通在后续随访中进展。

核心结论

  • MOCA是可行的门诊治疗选择,但技术成功率低于静脉腔内热消融。
  • 对于大直径静脉应谨慎考虑使用MOCA。

研究设计与样本

  • 随机对照试验,比较MOCA与EVLA和RFA治疗单侧GSV功能不全。
  • 132例符合纳入标准并愿意参与,随机分配比例为MOCA:EVLA:RFA=2:1:1。
  • 最终117例患者接受治疗。
  • 在治疗后1个月、1年和3年通过双功多普勒超声评估GSV状态并评估疾病特异性生活质量。

主要发现

  • 三年时MOCA闭塞率显著低于EVLA或RFA(82% vs 100%;P = .005)。
  • 各组间生活质量相似。
  • MOCA组术前GSV直径大于7 mm者随访期间更可能再通。
  • 一年时观察到的近端GSV部分再通在随访中进展。

关键数值与推荐

  • 三年闭塞率:MOCA 82% vs EVLA或RFA 100%(P = .005)。
  • MOCA组术前GSV直径大于7 mm与随访期再通相关。

临床怎么用

  • MOCA可作为门诊治疗选项,但需告知患者其技术成功率低于热消融。
  • 对大直径GSV(>7 mm)患者选择MOCA时应谨慎。
  • 术后应通过超声随访监测再通,尤其对于大直径静脉或早期部分再通者。

局限性

  • 部分患者随机后拒绝继续参与,最终仅117例接受治疗。
  • 原文未报告长期结果的具体随访时长外推性限制。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Mechanochemical ablation (MOCA) is a nonthermal nontumescent method of treating saphenous vein insufficiency. The feasibility and short-term results of MOCA are good, but its long-term results are unknown. A randomized study was performed to compare MOCA with endovenous laser ablation (EVLA) and radiofrequency ablation (RFA) in the setting of unilateral great saphenous vein (GSV) insufficiency. METHODS: Venous outpatient clinic patients with varicose veins (CEAP class C2-C4) caused by GSV insufficiency were invited to participate in the study; in total, 132 patients met the inclusion criteria and were willing to participate. Patients were randomized to treatment (2:1:1 for MOCA, EVLA, and RFA, respectively). The state of the GSV with duplex Doppler ultrasound examination and the disease-specific quality of life were assessed at 1 month, 1 year, and 3 years after the treatment. RESULTS: Some patients declined to continue in the study after randomization; in total, 117 patients underwent treatment. At 3 years, the occlusion rate was significantly lower with MOCA than with either EVLA or RFA (82% vs 100%; P = .005). Quality of life was similar between the groups. In the MOCA group, GSVs that were larger than 7 mm in diameter preoperatively were more likely to recanalize during the follow-up period. The partial recanalizations of proximal GSV observed at 1 year progressed during the follow-up. CONCLUSIONS: MOCA is a feasible treatment option in an outpatient setting, but its technical success rates are inferior compared with endovenous thermal ablation. Its use in large-caliber veins should be considered carefully.

来源:J Vasc Surg Venous Lymphat Disord,查看原文。版权归原作者所有。

引用

  1. Vähäaho S, Halmesmäki K, Mahmoud O, et al. Three-year results of a randomized controlled trial comparing mechanochemical and thermal ablation in the treatment of insufficient great saphenous veins. J Vasc Surg Venous Lymphat Disord. 2020. PMID: 32795619. doi:10.1016/j.jvsv.2020.08.007

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。